This topic examines secure generative AI platforms and agent infrastructures tailored for healthcare and other highly regulated sectors. Organizations now require platforms that combine strong data governance, end-to-end observability, and demonstrable compliance (data residency, HIPAA/GDPR controls, audit trails) alongside practical integration with clinical and enterprise workflows. Key categories include AI security governance, regulatory compliance tooling, and AI governance platforms. Platform types range from enterprise assistants (IBM watsonx Assistant, Microsoft 365 Copilot) that integrate with EHRs and productivity suites, to multi-agent orchestration systems (Kore.ai, Relevance AI) and agentic infrastructures (Xilos) that emphasize visibility and workflow control. Foundation-model providers and multimodal APIs (Mistral AI, Anthropic’s Claude family, Google Gemini) supply the underlying models and enterprise-grade deployments, often with options for private/hybrid hosting, fine-tuning, and provenance controls. Current trends driving adoption are tighter regulatory scrutiny in 2026, a shift toward open/efficient models for private deployments, and demand for immutable audit logs, role-based access, SIEM integration, and model versioning. Practical vendor capabilities to evaluate include observable agent activity (Xilos’s claimed visibility), governance and policy enforcement in orchestration platforms (Kore.ai), no-code/low-code agent lifecycle management (Relevance AI), and assistant products that support both no-code builders and developer-driven automation (watsonx Assistant, Microsoft 365 Copilot). Selecting the right secure GenAI platform depends on compliance requirements, data residency and integration needs, the desired level of agent autonomy, and governance/observability features. Organizations should prioritize provable controls and interoperability over vendor promises when assessing platforms for regulated use.